Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

A study found multiple protein abnormalities in many older brains

Original source

Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers.J Alzheimers Dis · 4 February 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human

Related topics

Researchers examined brain tissue from 1,825 deceased people and found Alzheimer’s disease neuropathological change in 64%. TDP-43 was among the proteins assessed, but the study did not report an ALS or motor neurone disease finding.

Why this matters

The results may be relevant to interpreting protein-based tests in older people, because multiple brain pathologies often occurred together. They do not establish an ALS/MND biomarker, diagnosis or treatment effect.

Limitations and context

This was a postmortem pathology study, not a clinical trial. Only 20% of participants had dementia, and the source does not provide an ALS/MND-specific analysis. The authors concluded that current tests cannot definitively distinguish the pathology causing cognitive impairment without postmortem assessment.

Summarised by Compass 19 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?